Trader Note — 9342 total
NTR enters the final week of June with an unusual internal tension: its CFO has been buying the stock on the way down, even as the price has dropped nearly 10% over the past month to CAD 87.32. The insider angle is the…
Baker Hughes heads into its July 21 earnings with a striking divergence: insiders have been selling heavily while options traders have shifted to their most bullish stance in months. The insider activity is the…
Esquire Financial Holdings heads into its July 24 earnings date with short interest quietly rebuilding and the ORTEX short score nudging to a fresh high — a setup worth watching on a stock with a notoriously tight…
ACM Research enters the back half of June with the most interesting tension in its story sitting squarely in the analyst suite — a stock that has surged 35% over the past month is now getting its price targets chased…
CVNA enters the final stretch before its July 24 earnings print with options traders ratcheting up defensive positioning — and a stock that has lost more than 7% on the week, now trading at $64.83. The options signal…
SNAP enters the back half of June with its sharpest divergence in weeks: options traders have turned dramatically more defensive even as the short-selling community quietly covers, creating an unusual split in how the…
Invitation Homes enters the final week before its July 22 earnings with a fresh analyst upgrade pulling against options positioning that remains more defensive than usual. Wells Fargo's James Feldman moved to…
AnaptysBio heads into the back half of June with its most striking divergence in months: options traders have turned sharply bullish while short sellers quietly add to one of biotech's larger short positions. The…
Alcoa enters the final week of June having shed 12% in five sessions, closing at $55.08 on Tuesday — a month-to-date loss of nearly 23% that has pushed the stock well below every analyst price target on the Street. The…
Orla Mining has shed 14.5% in a week — nearly double the drawdown of its closest gold peers — yet the most recent institutional filing shows Hamblin Watsa added more than 24 million shares, a tension that defines the…
BOTZ has dropped 9% in a month while short sellers rebuild positions at the fastest pace in weeks — a rare moment of genuine tension for an ETF that typically draws little bearish attention. The positioning story is…
International Seaways is up nearly 10% on the week and sitting at $89.98 — outpacing most of its tanker peers — yet options traders have simultaneously turned sharply more cautious, creating an unusual tension between…
Fortive Corporation heads into late June with a notable split between options traders bracing for downside and short sellers who have been quietly reducing their exposure — a tension that makes the current setup more…
SPCX has stabilised just above its post-IPO floor, but the lending market is sending a new signal — borrow availability has tightened sharply this week even as the cost to borrow fell back toward baseline. The most…
Alkermes enters the final week of June with a striking split: the stock has surged 30% in a month, analysts are chasing it higher with fresh target upgrades, yet a 10.4% short interest reading signals that a meaningful…
XYZ heads into the second half of June with an interesting split: options traders are the most bullish they've been in a year, while insiders have been quietly selling every day for two weeks. The options angle is the…
Wave Life Sciences heads into the final stretch before its mid-2026 FDA accelerated approval decision with short interest climbing, analyst targets sitting far above the current price, and options traders tilting…
XLRE enters the final week of June with its borrow market looser than it has been all year — a striking reversal from the squeeze conditions that dominated the first half of the month. The lending story this week is…
CC enters the week with a rare alignment of signals: the stock is down nearly 8% and options traders have abruptly shifted to their most defensive posture in months. The sharpest signal this week is in options. The…
Spyre Therapeutics enters the back half of June with a striking tension: the stock has rallied 16% in a week and 31% in a month, yet nearly a fifth of its free float remains borrowed against it. The options market has…
